98164705 - CRISPR THERAPEUTICS

Information

• Trademark
• 98164705

• Source

• Serial Number

  98164705

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  September 05, 2023
  a year ago

• Transaction Date

  January 01, 2025
  3 days ago

• Status Date

  December 16, 2024
  19 days ago

• Published for Opposition Date

  January 07, 2025
  2 days from now

• Location Date

  December 16, 2024
  19 days ago

• First Use Anywhere Date

  July 22, 2019
  5 years ago

• First Use In Commerce Date

  July 22, 2019
  5 years ago

• Status Code

  681

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  MCCRARY, LISA

• Attorney Docket Number

  33324/60079

  Attorney Name

  Tiffany D. Gehrke

  Law Office Assigned Location Code

  M50

• Owners

  • Crispr Therapeutics AG

Case File Statements

• GS0411: Education services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
• DM0000: The mark consists of an incomplete square with a break in the lower right of the square. At the bottom of the square below the break appears a shaded rectangle. In the lower middle of the square appears the stylized word "CRISPR", with the second "R" connected to the square. In the shaded rectangle appears the stylized word "THERAPEUTICS".
• GS0051: Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, infectious disease, autoimmune disorders, transplant rejections and inflammatory disease; pharmaceutical products and preparations, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders
• CC0000: Color is not claimed as a feature of the mark.
• DS0000: "THERAPEUTICS"
• GS0421: Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development, namely, providing medical and scientific research and development in the fields of pharmaceuticals and biopharmaceuticals; medical research laboratory services; scientific laboratory services; custom cell-line engineering services for scientific research purposes; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Case File Event Statements

• 9/8/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 9/28/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/29/2023 - a year ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 5/1/2024 - 8 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 5/10/2024 - 7 months ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 5/10/2024 - 7 months ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 5/10/2024 - 7 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 8/7/2024 - 5 months ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 8/7/2024 - 5 months ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/7/2024 - 5 months ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 12/10/2024 - 25 days ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/1/2025 - 3 days ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP